社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
ImmunityBio, Inc.(IBRX)
盘后
11.61
0.06
+0.52%
18:32 EST
11.55
+1.72
+17.50%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
ImmunityBio, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.immunitybio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。公司是一家领先的临床剂型的现成自然杀伤细胞疗法生产商，记忆NK细胞，连同抗体细胞因子融合蛋白、白蛋白结合化学免疫调节剂和疫苗载体的综合平台。通过结合这些NK、巨噬细胞和T细胞激活平台，该公司相信ImmunityBio在免疫治疗领域处于领先地位，具有跨越多种肿瘤类型和传染病的后期临床开发。
02-24 06:24
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
02-24 05:28
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
02-23 13:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-18
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-26
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-21
关联方拟减持公告
Form 144 | IMMUNITYBIO董事 Christobel Selecky 拟减持25000股，总价约13.8万美元
Form 144 | IMMUNITYBIO董事 Christobel Selecky 拟减持25000股，总价约13.8万美元
01-20
关联方拟减持公告
Form 144 | ImmunityBio高管兼董事 Simon Barry J.拟减持571967股，总价约590万美元
Form 144 | ImmunityBio高管兼董事 Simon Barry J.拟减持571967股，总价约590万美元
01-16
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
01-15
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-24
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-12
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-05
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
分时
5日
日
周
月
数据加载中...
最高
12.28
今开
10.15
量比
1.47
最低
9.95
昨收
9.83
换手率
24.69%
热议股票
{"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"IBRX","data":{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":11.55,"timestamp":1771966800000,"preClose":9.83,"halted":0,"volume":82956211,"hourTrading":{"tag":"盘后","latestPrice":11.61,"preClose":11.55,"latestTime":"18:32 EST","volume":453688,"amount":5233528.358824,"timestamp":1771975932157,"change":0.06,"changeRate":0.005195,"amplitude":0.032035},"delay":0,"changeRate":0.17497456765005093,"floatShares":336000000,"shares":1027999999,"eps":-0.415322,"marketStatus":"盘后交易","change":1.72,"latestTime":"02-24 18:32:39 EST","open":10.15,"high":12.28,"low":9.95,"amount":934216306.0710546,"amplitude":0.23703,"askPrice":11.66,"askSize":2,"bidPrice":11.6,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-0.415322,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":9.83,"preHourTrading":{"tag":"盘前","latestPrice":10.17,"preClose":9.83,"latestTime":"09:29 EST","volume":1044525,"amount":10606222.792275,"timestamp":1771943396338,"change":0.34,"changeRate":0.034588,"amplitude":0.084435},"postHourTrading":{"tag":"盘后","latestPrice":11.61,"preClose":11.55,"latestTime":"18:32 EST","volume":453688,"amount":5233528.358824,"timestamp":1771975932157,"change":0.06,"changeRate":0.005195,"amplitude":0.032035},"volumeRatio":1.471608,"optionData":{"bulkOrders":[{"symbol":"IBRX","call":false,"expireDate":1773979200000,"strike":"10.0","timestamp":1771955698457,"price":1.05,"volume":2000,"amount":210000,"type":"+"},{"symbol":"IBRX","call":true,"expireDate":1773979200000,"strike":"6.0","timestamp":1771951617731,"price":5.2,"volume":1500,"amount":780000,"type":"+"}]},"impliedVol":1.7008,"impliedVolPercentile":0.9641},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20758247","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000030-IBRX","pdf_url":"","pub_time":1771885470000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"IBRX","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1326110/0001326110-26-000030-index.html","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231.htm","primary":true,"translateUrl":"","linkName":"ibrx-20251231.htm","type":"10-K","id":"NTFILE8q42DYqZ1QUHoQST","market":"us","size":4370682},{"description":"EX-3.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit31.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit31.htm","type":"EX-3.1","id":"NTFILE5TGA32CcJsW1rH6S","market":"us","size":34312},{"description":"EX-10.34","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kex1034.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kex1034.htm","type":"EX-10.34","id":"NTFILE6hDp9e7wHdkZHSnn","market":"us","size":94235},{"description":"EX-21.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit211.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit211.htm","type":"EX-21.1","id":"NTFILE91Y687o9vPFMtjxj","market":"us","size":19019},{"description":"EX-23.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit231.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit231.htm","type":"EX-23.1","id":"NTFILE6b7M2yZQJN3wnNS9","market":"us","size":3165},{"description":"EX-23.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit232.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit232.htm","type":"EX-23.2","id":"NTFILEHMt9b8Dv96ZQhscE","market":"us","size":7647},{"description":"EX-31.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit311.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit311.htm","type":"EX-31.1","id":"NTFILEGvK2qZxz7xH4mEVp","market":"us","size":11266},{"description":"EX-31.2","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit312.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit312.htm","type":"EX-31.2","id":"NTFILE7M6j5gjRgLCdDbyH","market":"us","size":11251},{"description":"EX-32.1","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit321.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit321.htm","type":"EX-32.1","id":"NTFILEBZDuAG7GRSiyh6Sg","market":"us","size":5510},{"description":"EX-32.2","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231x10kexhibit322.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251231x10kexhibit322.htm","type":"EX-32.2","id":"NTFILEcZhkscz7e7AWerBH","market":"us","size":5011},{"description":"IMAGE","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g1.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g1.jpg","type":"GRAPHIC","id":"NTFILEsEYV12aAE6khzCwC","market":"us","size":73138},{"description":"IMAGE","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g10.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g10.jpg","type":"GRAPHIC","id":"NTFILE9SkzTAAmqQoitwgi","market":"us","size":248392},{"description":"PERFORMANCE GRAPH","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g11.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g11.jpg","type":"GRAPHIC","id":"NTFILE122yy1D13KDRYfzi","market":"us","size":90832},{"description":"IMAGE","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g2.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g2.jpg","type":"GRAPHIC","id":"NTFILE3VZrC29oP2TneWhi","market":"us","size":97052},{"description":"IMAGE","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g3.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g3.jpg","type":"GRAPHIC","id":"NTFILEBNLUm5kFkfGEu36r","market":"us","size":38808},{"description":"IMAGE","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g4.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g4.jpg","type":"GRAPHIC","id":"NTFILE63E96iChUGgfUJxG","market":"us","size":348886},{"description":"IMAGE","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g5.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g5.jpg","type":"GRAPHIC","id":"NTFILE6tHwH14XopXgfcXc","market":"us","size":390290},{"description":"IMAGE","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g6.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g6.jpg","type":"GRAPHIC","id":"NTFILEAgXp9iyzbsy8MWSE","market":"us","size":925677},{"description":"IMAGE","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g7.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g7.jpg","type":"GRAPHIC","id":"NTFILEAVpwA66CYnRaRnqJ","market":"us","size":60779},{"description":"IMAGE","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g8.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g8.jpg","type":"GRAPHIC","id":"NTFILEJEHG6Emx4NgmXWiq","market":"us","size":118394},{"description":"IMAGE","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000030/ibrx-20251231_g9.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20251231_g9.jpg","type":"GRAPHIC","id":"NTFILEEaTjtQHJ6V3kKMrg","market":"us","size":1884972}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2026-02-24 06:24","pubTimestamp":1771885470,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20758253","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726001638-IBRX","pdf_url":"","pub_time":1771882106000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"IBRX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/0001950047-26-001638-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000195004726001638/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEDADCiGFAuuqvLX6Q","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-02-24 05:28","pubTimestamp":1771882106,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"20755645","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000025-IBRX","pdf_url":"","pub_time":1771822800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000025/0001326110-26-000025-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000025/ibrx-2026223x8kexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-2026223x8kexhibit991.htm","type":"EX-99.1","id":"NTFILEHZKArw3ehadhnWat","market":"us","size":173258},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000025/ibrx-20260223.htm","primary":false,"translateUrl":"","linkName":"ibrx-20260223.htm","type":"8-K","id":"NTFILEA5C8n9UXLBkb3soP","market":"us","size":30052},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000025/image_0a.jpg","primary":false,"translateUrl":"","linkName":"image_0a.jpg","type":"GRAPHIC","id":"NTFILE3GPpA85qBEwyMkqU","market":"us","size":2549}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-23 13:00","pubTimestamp":1771822800,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20745304","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000018-IBRX","pdf_url":"","pub_time":1771390800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000018/0001326110-26-000018-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000018/ibrx-20262188xkexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-20262188xkexhibit991.htm","type":"EX-99.1","id":"NTFILEDesSEA5rVMAEyvep","market":"us","size":39882},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000018/ibrx-20260218.htm","primary":false,"translateUrl":"","linkName":"ibrx-20260218.htm","type":"8-K","id":"NTFILE35FPtdBThQK1yCzW","market":"us","size":29414},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000018/immunitybio-logox2024xcolo.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcolo.jpg","type":"GRAPHIC","id":"NTFILE2hBJqjebcZWJZN4c","market":"us","size":31902}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-18 13:00","pubTimestamp":1771390800,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20662573","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000014-IBRX","pdf_url":"","pub_time":1769403600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000014/0001326110-26-000014-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000014/ibrx-20261238xkexhibit101.htm","primary":true,"translateUrl":"","linkName":"ibrx-20261238xkexhibit101.htm","type":"EX-10.1","id":"NTFILEGZy7S8C1TBgKmDa1","market":"us","size":23351},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000014/ibrx-20260123.htm","primary":false,"translateUrl":"","linkName":"ibrx-20260123.htm","type":"8-K","id":"NTFILE8VNvuAGVCPnEKVLM","market":"us","size":29994}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-26 13:00","pubTimestamp":1769403600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20647362","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726000561-IBRX","pdf_url":"","pub_time":1768944584000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"IBRX","title":"Form 144 | IMMUNITYBIO董事 Christobel Selecky 拟减持25000股，总价约13.8万美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/0001950047-26-000561-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | IMMUNITYBIO董事 Christobel Selecky 拟减持25000股，总价约13.8万美元","gpt_en_title":"Form 144 | IMMUNITYBIO's Director Christobel Selecky proposes to sell 25000 shares, with a total value of approximately $138,000.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000195004726000561/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEDTMsg39ZR8dGkJWM","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-01-21 05:29","pubTimestamp":1768944584,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"20645615","market":"us","labels":[],"media":"sec.gov","original_id":"AN194984626000009-IBRX","pdf_url":"","pub_time":1768885200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"IBRX","title":"Form 144 | ImmunityBio高管兼董事 Simon Barry J.拟减持571967股，总价约590万美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000194984626000009/0001949846-26-000009-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | ImmunityBio高管兼董事 Simon Barry J.拟减持571967股，总价约590万美元","gpt_en_title":"Form 144 | ImmunityBio's Officer and Director Simon Barry J. proposes to sell 571,967 Shares, with a total value of approximately $5.90 Million.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000194984626000009/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEBQ1RcaLnuvpBRMYW","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-01-20 13:00","pubTimestamp":1768885200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"20640443","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726000516-IBRX","pdf_url":"","pub_time":1768539600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"IBRX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000195004726000516/0001950047-26-000516-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000195004726000516/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE29sYHh4ZUWKwQXh7","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-01-16 13:00","pubTimestamp":1768539600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20635254","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000008-IBRX","pdf_url":"","pub_time":1768453200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/0001326110-26-000008-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/ibrx-20261158xkexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-20261158xkexhibit991.htm","type":"EX-99.1","id":"NTFILE7jtw7uEqSXtTSYRT","market":"us","size":21400},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/ibrx-20260115.htm","primary":false,"translateUrl":"","linkName":"ibrx-20260115.htm","type":"8-K","id":"NTFILEBH1pVydd1iKSGNRL","market":"us","size":30539},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/immunitybio-logox2024xcoloa.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcoloa.jpg","type":"GRAPHIC","id":"NTFILE5U3prMBFJxaPtTEg","market":"us","size":31902}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-15 13:00","pubTimestamp":1768453200,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20631592","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000004-IBRX","pdf_url":"","pub_time":1768366800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/0001326110-26-000004-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/ibrx-20261148xkexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-20261148xkexhibit991.htm","type":"EX-99.1","id":"NTFILEFcSgW4shVXcsfx63","market":"us","size":22145},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/ibrx-20260114.htm","primary":false,"translateUrl":"","linkName":"ibrx-20260114.htm","type":"8-K","id":"NTFILEB5q1TYYVGNpVDRSj","market":"us","size":33306},{"description":"EX-99.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/ibrx-20261148xkexhibit992.htm","primary":false,"translateUrl":"","linkName":"ibrx-20261148xkexhibit992.htm","type":"EX-99.2","id":"NTFILE2B5sy7CN2D5n2Fvc","market":"us","size":22612},{"description":"IMMUNITYBIO LOGO","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/immunitybio-logox2024xcoloa.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcoloa.jpg","type":"GRAPHIC","id":"NTFILEAfV9JyXWjPx75qXU","market":"us","size":31902},{"description":"IMMUNITYBIO LOGO","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/immunitybio-logox2024xcolob.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcolob.jpg","type":"GRAPHIC","id":"NTFILEDyZBDVsCncr2fsC9","market":"us","size":31902}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-14 13:00","pubTimestamp":1768366800,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20580199","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525331244-IBRX","pdf_url":"","pub_time":1766535940000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/0001193125-25-331244-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833dex31.htm","primary":true,"translateUrl":"","linkName":"d61833dex31.htm","type":"EX-3.1","id":"NTFILE5wn9Q63ra72RhjHU","market":"us","size":5815},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833d8k.htm","primary":false,"translateUrl":"","linkName":"d61833d8k.htm","type":"8-K","id":"NTFILE3d9pjERon5F1on9x","market":"us","size":32268},{"description":"EX-5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833dex51.htm","primary":false,"translateUrl":"","linkName":"d61833dex51.htm","type":"EX-5.1","id":"NTFILE99BfwEG3xoeByXRQ","market":"us","size":9107},{"description":"EX-10.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833dex101.htm","primary":false,"translateUrl":"","linkName":"d61833dex101.htm","type":"EX-10.1","id":"NTFILE7zNG17bKojG1yY8N","market":"us","size":14520},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/g61833g1223191314206.jpg","primary":false,"translateUrl":"","linkName":"g61833g1223191314206.jpg","type":"GRAPHIC","id":"NTFILE86JjTW2UH1EDimQs","market":"us","size":3107}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-24 08:25","pubTimestamp":1766535940,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20536193","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000146-IBRX","pdf_url":"","pub_time":1765833953000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/0001326110-25-000146-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000146/ibrx-20251210.htm","primary":true,"translateUrl":"","linkName":"ibrx-20251210.htm","type":"8-K","id":"NTFILE6CzpzHSQpXYNAyHd","market":"us","size":32964}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-16 05:25","pubTimestamp":1765833953,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20525570","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000143-IBRX","pdf_url":"","pub_time":1765515600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/0001326110-25-000143-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/ibrx-202512128xkexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-202512128xkexhibit991.htm","type":"EX-99.1","id":"NTFILEB5yJ4fNaqfqqVwK7","market":"us","size":24293},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/ibrx-20251212.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251212.htm","type":"8-K","id":"NTFILEAyUjHmMNFuHqC7bF","market":"us","size":28173},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/immunitybio-logox2024xcolo.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcolo.jpg","type":"GRAPHIC","id":"NTFILEFDzpSeZWPCBUZPPs","market":"us","size":31902}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-12 13:00","pubTimestamp":1765515600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20371815","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000138-IBRX","pdf_url":"","pub_time":1762318800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/0001326110-25-000138-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/ibrx-2025114x8kexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-2025114x8kexhibit991.htm","type":"EX-99.1","id":"NTFILEGdK2TmNKEiv1ZdUk","market":"us","size":130959},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/ibrx-20251104.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251104.htm","type":"8-K","id":"NTFILE2Vs52nXkAsFR7Tep","market":"us","size":30854},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILE7WUdgmtrtNEUD5v2","market":"us","size":2549}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-05 13:00","pubTimestamp":1762318800,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20371801","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000139-IBRX","pdf_url":"","pub_time":1762318800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"IBRX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/0001326110-25-000139-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-20250930.htm","primary":true,"translateUrl":"","linkName":"ibrx-20250930.htm","type":"10-Q","id":"NTFILED3qt9N3AECYVqGfX","market":"us","size":3282741},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit311.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit311.htm","type":"EX-31.1","id":"NTFILEF6npygf8KB3CMTL9","market":"us","size":11147},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit312.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit312.htm","type":"EX-31.2","id":"NTFILECkYvchTytivrjJ6o","market":"us","size":10915},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit321.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit321.htm","type":"EX-32.1","id":"NTFILEGticmPyxN73vEDpY","market":"us","size":5206},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit322.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit322.htm","type":"EX-32.2","id":"NTFILE7JmRACFFQZVL3R6L","market":"us","size":4951},{"description":"2025 PIPELINE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-20250930_g1.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20250930_g1.jpg","type":"GRAPHIC","id":"NTFILEEo5m59DdPcpPo9Xz","market":"us","size":174354}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-05 13:00","pubTimestamp":1762318800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":0.6535},{"period":"1month","weight":0.524},{"period":"3month","weight":3.726},{"period":"6month","weight":3.2009},{"period":"1year","weight":1.8743},{"period":"ytd","weight":3.9646}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。公司是一家领先的临床剂型的现成自然杀伤细胞疗法生产商，记忆NK细胞，连同抗体细胞因子融合蛋白、白蛋白结合化学免疫调节剂和疫苗载体的综合平台。通过结合这些NK、巨噬细胞和T细胞激活平台，该公司相信ImmunityBio在免疫治疗领域处于领先地位，具有跨越多种肿瘤类型和传染病的后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.219152},{"month":2,"riseRate":0.545455,"avgChangeRate":0.076452},{"month":3,"riseRate":0.3,"avgChangeRate":-0.083879},{"month":4,"riseRate":0.5,"avgChangeRate":0.021643},{"month":5,"riseRate":0.4,"avgChangeRate":0.054052},{"month":6,"riseRate":0.3,"avgChangeRate":0.132356},{"month":7,"riseRate":0.4,"avgChangeRate":-0.029239},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.110134},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.03348},{"month":10,"riseRate":0.454545,"avgChangeRate":0.029893},{"month":11,"riseRate":0.636364,"avgChangeRate":0.121867},{"month":12,"riseRate":0.363636,"avgChangeRate":0.048951}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"aProfile":null}}}